Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emmessar Biotech & Nutrition Ltd has submitted a compliance certificate for Q4 FY2026 (January-March 2026) as required under SEBI regulations. The certificate from their Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms that securities received for dematerialisation during the quarter were properly processed and accepted or rejected. The Registrar also confirms that physical share certificates were mutilated and cancelled after verification, and depository names were updated in the register of members within prescribed timelines. This is a routine regulatory filing required every quarter to confirm proper handling of share dematerialisation requests.
No direct impact on stock price. This is a standard regulatory compliance filing confirming that share dematerialisation processes were handled correctly during the quarter. Investors can note that the company's share transfer procedures remain compliant with SEBI requirements.